van der Neut Kolfschoten, M
Full activation isn't necessary because modest receptor signaling can still drive important metabolic and cardiovascular benefits
While patients benefitting from anti-obesity medications, such as GLP-1 therapies, may find some relief from sleep-related challenges or symptoms, its important to remain aware of potential underlying or persistent sleep issues, especially once patients have stopped using these medications and are tasked with the life-long challenge of weight management
Reported benefits (per available research): Studied for its ability to produce sustained, dose-dependent increases in growth hormone and IGF-1 secretion in a Phase 1 human trial in healthy adults, published by Teichman et al
The Risk All Four Medications Share And How LeanMD Addresses It Regardless of which GLP-1 weight loss medication you take, all four carry the same critical risk: loss of lean muscle mass alongside fat